Filter Results:
(994)
Show Results For
- All HBS Web
(994)
- People (4)
- News (257)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(994)
- People (4)
- News (257)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
- 06 Jul 2015
- News
Lights! Camera... Market!
to move away, while the other rejects farm life to pursue a bigger payday smuggling drugs over the Canadian border. It’s a tough but touching story with a very un-Hollywood ending. Yet, for Jared Simon (MBA 2008), the making—and... View Details
- 01 Sep 2006
- News
Redefining Health Care
high costs understandable. What Wennberg and others did was to show that U.S. health care also has severe quality problems. Indeed, there is every possible quality problem you can imagine: incorrect diagnoses, drug errors, unnecessary... View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Although Novartis would improve its position in oncology by acquiring GSK’s promising drug portfolio, it had to sell its vaccines and animal health businesses, while giving up control of the over-the-counter (OTC) business. Jimenez and... View Details
Keywords: Carmen Nobel
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
with multiple myeloma, a rare and incurable blood cancer, Kathy Giusti cofounded the Multiple Myeloma Research Foundation, which has helped thousands of other patients with the cancer and has accelerated drug discovery and development for... View Details
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
"Transforming Life, Transforming Business: The Life-Science Revolution," a McKinsey Award-winning article he coauthored in the March-April 2000 issue of Harvard Business Review. "As distinctions between food and medicine fade, we will see a proliferation... View Details
- 01 Dec 2020
- News
Quantum Leap
process of drug development: With quantum’s ability to analyze multiple molecules, proteins, and chemicals at the same time, researchers could significantly speed the time to market with ultrafast and high-volume testing—and discover new... View Details
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and... View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 17 Oct 2012
- Research & Ideas
America Needs a Manufacturing Renaissance
sciences that laid the institutional foundations for innovations in semiconductors, high-speed computers, computer graphics, broadband communications, mobile telephony, the Internet, and modern genomics-based methods of drug discovery.... View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 17 Nov 2008
- Research & Ideas
Decoding the Artful Sidestep
There are two findings that we find most interesting. First, it is striking that participants failed to punish the speaker when he dodged the question asked. For example, the speaker paid no price for answering a question about the illegal View Details
Keywords: by Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
information standards in accounting (through the Financial Accounting Standards Board) and in food labeling (through the Food and Drug Administration). There are likely lessons for both regulatory agencies in such a comparative analysis. View Details
Keywords: by Martha Lagace
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 08 Jan 2008
- First Look
First Look: January 8, 2008
to unaccounted capital flight. Download the paper: http://www.hbs.edu/research/pdf/07-074.pdf Cases & Course MaterialsAntegren: A Beacon of Hope Harvard Business School Case 408-025 The CEO of Biogen Idec faces a set of difficult decisions regarding a promising... View Details
Keywords: Martha Lagace
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
series of contact-lens products, introduced a drug for treating age-related macular degeneration, pioneered a new lens-manufacturing process that dramatically reduced production costs, and overtook J&J in some market segments. The... View Details
- 15 Feb 2000
- Lessons from the Classroom
Delivering Information Services: A 30-Year Perspective
IPO in 1990 to a $10-billion company today, with a market value of close to $140 billion! I'm also doing research for a case on Drugstore.com, which is essentially a drug store "built" on the Internet. It's getting ready to... View Details
Keywords: by Staff
- 16 May 2018
- News
ALUMNI NVC Finals and Regional Roundup
2015) told an audience of 500 that DynamiCare Health uses a digital platform to monitor and reward addicts for active recovery efforts, eliminating degrading methods of drug testing. DynamiCare took the top prize of $75,000. George... View Details
Keywords: Margie Kelley
- 15 Apr 2008
- First Look
First Look: April 15, 2008
destructive behaviors such as cutting, excessive use of alcohol, taking drugs and suicide attempts. These patients are very difficult to treat and TBC has developed programs that make a noticeable difference to these patients. DBT... View Details
Keywords: Martha Lagace
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped... View Details
Keywords: Martha Lagace
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed not only to illegalize the... View Details
Keywords: by Carmen Nobel & Anna Secino